Evidence map›Paper›PMID 35056748›Full record

ArticleMolecules (Basel, Switzerland)2022

Bispidine Platform as a Tool for Studying Amide Configuration Stability.

Dmitry P Krut'ko, Alexey V Medved'ko, Konstantin A Lyssenko, Andrei V Churakov, Alexander I Dalinger, Mikhail A Kalinin, Alexey O Gudovannyy, Konstantin Y Ponomarev, Eugeny V Suslov, Sergey Z Vatsadze

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Novel Complexes of 3-[3-(1Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dmitry P Krut'koChemistry Department, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia.
Alexey V Medved'koZelinsky Institute of Organic Chemistry, 119991 Moscow, Russia.ORCID 0000-0002-8731-6934
Konstantin A LyssenkoChemistry Department, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia.
Andrei V ChurakovN.S. Kurnakov Institute of General and Inorganic Chemistry, 119991 Moscow, Russia.ORCID 0000-0003-3336-4022
Alexander I DalingerChemistry Department, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia.
Mikhail A KalininChemistry Department, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia.ORCID 0000-0002-0056-4813
Alexey O GudovannyyChemistry Department, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia.
Konstantin Y PonomarevN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, 630090 Novosibirsk, Russia.
Eugeny V SuslovN.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, 630090 Novosibirsk, Russia.ORCID 0000-0003-0988-0502
Sergey Z VatsadzeChemistry Department, Lomonosov Moscow State University, Leninskie Gory, 119991 Moscow, Russia.ORCID 0000-0001-7884-8579

Funding

Russian Foundation for Basic Research 20-03-00867Russian Science Foundation 19-73-20090
6 · The paper itself

Abstract

In this work, the solution conformations of seventeen 3,7-diacyl bispidines were studied by means of NMR spectroscopy including VT NMR experiments. The acyl groups included alkyl, alkenyl, aryl, hetaryl, and ferrocene moieties. The presence of syn/anti-isomers and their ratios were estimated, and some reasons explaining experimental facts were formulated. In particular, all aliphatic and heterocyclic units in the acylic R(CO) fragments led to an increased content of the

Indexed as

3,7-diazabicyclo[3.3.1]nonanesbarriers of amide rotationdynamic stereochemistryNMR spectroscopyquantum chemical calculationsX-ray diffraction study

Identifiers

PMID35056748
PMCPMC8779339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.